Toxoplasmosis: the first commercial vaccine
- 1 January 1993
- journal article
- Published by Elsevier in Parasitology Today
- Vol. 9 (9) , 335-337
- https://doi.org/10.1016/0169-4758(93)90236-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Treatment of ovine toxoplasmosis with a combination of sulphamezathine and pyrimethamineVeterinary Record, 1993
- Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.The Journal of Experimental Medicine, 1992
- Passive immunization protects guinea pigs from lethal toxoplasma infectionFEMS Microbiology Letters, 1992
- Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccineVaccine, 1991
- Toxoplasmosis in sheep and other farm animalsIn Practice, 1989
- Toxoplasmosis in sheep III. Further evaluation of the ability of a liveToxoplasma gondiivaccine to prevent lamb losses and reduce congenital infection following experimental oral challengeNew Zealand Veterinary Journal, 1988
- Immunizing Effects in Mice of two Toxoplasma gondii Iscom PreparationsJournal of Veterinary Medicine, Series B, 1988
- Toxoplasmosis in sheep II. The ability of a live vaccine to prevent lamb losses after an intravenous challenge withToxoplasma gondiiNew Zealand Veterinary Journal, 1988
- Toxoplasmosis in sheep I. Effect of a killed vaccine on lambing losses caused by experimental challenge withToxoplasma gondiiNew Zealand Veterinary Journal, 1987
- Effect of Murine Interferon Gamma on Murine ToxoplasmosisThe Journal of Infectious Diseases, 1984